K-pop

143 Entertainment, Icon’s Agency, Appoints Koji Masai as First Chairman

Korean-Japanese Businessman Running an IP Investment Firm "Pushing to Expand Artist IP Through New Artist Launches and More"

KIM HYUNSIK
2026-07-20 11:51:06
[Edaily Starin KIM HYUNSIK Reporter] 143 Entertainment announced on the 20th that it has appointed Koji Masai, a Korean-Japanese businessman, as its first chairman.
From left: Maydin, Chairman Koji Masai, iKON (Photo courtesy of 143 Entertainment)
143 Entertainment is the agency representing the boy group iKON and the girl group Maydin. Creative Farm, led by Chairman Koji Masai, operates Masai Holdings, an entertainment intellectual property (IP) investment company.
143 Entertainment explained, “Chairman Koji Masai has developed various businesses based on real estate investments, and while continuously investing in the entertainment industry, he has shown interest in expanding Korean artists’ activities in Japan and cultural projects.”
143 Entertainment also announced that it has signed a strategic investment agreement with Creative Farm. Based on this agreement, the company plans to expand its artist IP portfolio, including the launch of new groups.
143 Entertainment added, “We plan to sequentially launch new boy groups and girl groups in the future and strive to expand our portfolio by recruiting competitive, high-profile artists.”
Chairman Koji Masai stated, “I highly value 143 Entertainment’s content competitiveness and growth potential,” adding, “I will do my part to ensure the company’s sustained growth through responsible investment and stable support.”

Economy

Corporation

IT·Science

Economy

[Market Insight] SK Eco and KCC Corporation Break Through the Construction Industry Slump… ‘Structural Reforms and Asset Value’ Opened Investors’ Wallets

SK Eco Plant and KCC Corporation(002380)achieved a successful public offering of corporate bonds, drawing a favorable response in the bookbuilding process despite significant uncertainty caused by a s…
2026-07-25 08:06:03

Corporation

[Blue Ocean Veterinary Medical Devices] ④ Precision Biosensor Inc. on the Verge of Reaching 10 Billion Won in Veterinary Diagnostics Sales

As medical technology advances, the treatment of human diseases is evolving toward “personalized” and “precision medicine.” Consequently, demand for personalized treatment and precision medicine is no…
2026-07-25 08:16:02

IT·Science

Kolon TissueGene, Inc. Faces Clinical Setback, Samsung BioLogics Secures ‘Big Deal’… A Mixed Week for Biotech [Weekly Biotech Roundup]

From July 20 to 24, the pharmaceutical and biotech industry was rocked by news that Kolon TissueGene, Inc.(950160)failed to achieve statistical significance in the U.S. Phase 3 clinical trial of its o…
2026-07-25 08:31:03